Jason M. Walsh
Gründer bei Provenance Biopharmaceuticals Corp.
Profil
Jason M.
Walsh founded Provenance Biopharmaceuticals Corp.
in 2008, where he is working as Chief Business Officer & Senior Vice President from 2008.
Mr. Walsh also currently works at Bioscience Network, Inc., as President.
Mr. Walsh also formerly worked at Lexigen Pharmaceuticals Corp., as Director-Finance & Business Operations and Merck KGaA, as Principal.
Mr. Walsh received his Masters Business Admin degree from Babson College and undergraduate degree from the University of Massachusetts.
Aktive Positionen von Jason M. Walsh
| Unternehmen | Position | Beginn |
|---|---|---|
Provenance Biopharmaceuticals Corp.
 Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Gründer | 01.01.2008 |
| Bioscience Network, Inc. | Präsident | 26.10.2010 |
Ehemalige bekannte Positionen von Jason M. Walsh
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Finanzdirektor/CFO | - |
Ausbildung von Jason M. Walsh
| Babson College | Masters Business Admin |
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
| Bioscience Network, Inc. |
